Skip to main content

Fan Yu

SEC CIK
0001668029
Latest filing
Aug 14, 2026

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Sep 17, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
4
−1 vs. Q1 2021
Portfolio value
$8.85M
−$29.5M (−76.9%) vs. Q1 2021
Filed
Sep 17, 2021
AmendedSEC
Holdings of Fan Yu in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
ABGIABG Acquisition Corp. ICL A SHS501,300$4.91M55.5%00.0%UnchangedHistory
AVIRAtea Pharmaceuticals, Inc.COM143,867$3.09M34.9%−156,133−52.0%ReducedHistory
SYRESpyre Therapeutics, Inc.COM112,044$780.0K8.8%00.0%UnchangedHistory
Diffusion Pharmaceuticals IN253748305COM PAR89,848$66.0K0.7%00.0%Unchanged–

Sold out since Q1 2021 (1)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Fan Yu sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
LUNGPulmonx CorpCOM303,030$13.9M36.2%History